Premium
SU‐E‐T‐368: Effect of a Strong Magnetic Field On Select Radiation Dosimeters
Author(s) -
Mathis M,
Wen Z,
Tailor R,
Sawakuchi G,
Flint D,
Beddar S,
Ibbott G
Publication year - 2014
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4888701
Subject(s) - dosimeter , dosimetry , thermoluminescent dosimeter , truebeam , irradiation , magnetic field , nuclear medicine , materials science , linear particle accelerator , medical physics , physics , beam (structure) , optics , medicine , nuclear physics , quantum mechanics
Purpose: To determine the effect of a strong magnetic field on TLD‐100, OSLD (Al 2 O 2 :C), and PRESAGE dosimetry devices. This study will help to determine which types of dosimeters can be used for quality assurance and in‐vivo dosimetry measurements in a magnetic resonance imaginglinear accelerator (MRI‐linac) system. Methods: The dosimeters were separated into two categories which were either exposed or not exposed to a strong magnetic field. In each category a set of dosimeters was irradiated with 0, 2, or 6 Gy. To expose the dosimeters to a magnetic field the samples in that category were place in a Bruker small animal magnetic resonance scanner at a field strength slightly greater than 2.5 T for at least 1 hour preirradiation and at least 1 hour post‐irradiation. Irradiations were performed with a 6 MV x‐ray beam from a Varian TrueBeam linac with 10×10 cm 2 field at a 600 MU/min dose rate. The samples that received no radiation dose were used as control detectors. Results: The readouts of the dosimeters which were not exposed to a strong magnetic field were compared with the measurements of the dosimetry devices which were exposed to a magnetic field. No significant differences (less than 2% difference) in the performance of TLD, OSLD, or PRESAGE dosimeters due to exposure to a strong magnetic field were observed. Conclusion: Exposure to a strong magnetic field before and after irradiation does not appear to change the dosimetric properties of TLD, OSLD, or PRESAGE which indicates that these dosimeters have potential for use in quality assurance and in‐vivo dosimetry in a MRI‐linac. We plan to further test the effect of magnetic fields on these devices by irradiating them in the presence of a magnetic fields similar to those produced by a MRI‐linac system. Elekta‐MD Anderson Cancer Center Research Agreement